- Austria / Österreich
- Bosnia and Herzegovina / Босна и Херцеговина
- Bulgaria / България
- Croatia / Hrvatska
- Czech Republic & Slovakia / Česká republika & Slovensko
- France / France
- Germany / Deutschland
- Greece / ΕΛΛΑΔΑ
- Italy / Italia
- Netherlands / Nederland
- Nordic / Nordic
- Poland / Polska
- Portugal / Portugal
- Romania & Moldova / România & Moldova
- Slovenia / Slovenija
- Serbia & Montenegro / Србија и Црна Гора
- Spain / España
- Switzerland / Schweiz
- Turkey / Türkiye
- UK & Ireland / UK & Ireland
BASEL, Switzerland: With implant dentistry continually developing and evolving, so too are some of the low-cost options. In a recent move to secure a larger stake in that market, Straumann recently signed agreements to buy further shares in T-Plus, a Taiwanese dental implant manufacturer. Once the Taiwanese Investment Commission has approved the purchase, Straumann will gain a 60 per cent share in the company.
T-Plus develops and manufactures attractively priced dental implant systems, which are sold exclusively through distributors in Taiwan and China. Its portfolio includes three tapered implant designs and covers a broad range of indications and customer preferences. The concepts, features and quality are similar to those of popular implant brands, something that Straumann believes makes T-Plus an attractive, inexpensive option for dentists using systems like Osstem and Astra.
Straumann first entered the non-premium market two years ago with a 30 per cents take in the France-based dental implant systems manufacturer Anthogyr. They have now reported that in Asia more than six million non-premium implants are sold annually, of which more than a third are low-cost.
“T-Plus provides us with the additional product ranges, registrations and brand to penetrate the entire non-premium segment in Taiwan and mainland China. In addition, it provides us with a modern, certified manufacturing facility in Asia. The company has a good track record and is well positioned for international growth, supported by the Straumann Group’s global presence, network and expertise,” said Patrick Loh, Head of Sales in Asia Pacific.
Tags:
Mon. 22 April 2024
10:00 am EST (New York)
Precision in practice: Elevating clinical communication
Fri. 26 April 2024
12:00 pm EST (New York)
How you can access data-driven decision making
Wed. 22 May 2024
12:00 pm EST (New York)
Leveraging the TLX implant concept in fast and efficient treatment protocols
Wed. 29 May 2024
5:00 am EST (New York)
Treatment of periimplantitis: Electro-chemical cleaning of the implant
Thu. 7 November 2024
12:00 pm EST (New York)
Leveraging the TLX ProArch concept in fully digital workflows to provide efficient full-arch rehabilitations with optimal peri-implant health
webinar
To post a reply please login or register